Success Metrics

Clinical Success Rate
84.6%

Based on 55 completed trials

Completion Rate
85%(55/65)
Active Trials
5(6%)
Results Posted
53%(29 trials)
Terminated
10(12%)

Phase Distribution

Ph not_applicable
17
20%
Ph phase_2
15
18%
Ph phase_3
16
19%
Ph phase_4
28
33%
Ph phase_1
7
8%

Phase Distribution

7

Early Stage

15

Mid Stage

44

Late Stage

Phase Distribution83 total trials
Phase 1Safety & dosage
7(8.4%)
Phase 2Efficacy & side effects
15(18.1%)
Phase 3Large-scale testing
16(19.3%)
Phase 4Post-market surveillance
28(33.7%)
N/ANon-phased studies
17(20.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.7%

55 of 69 finished

Non-Completion Rate

20.3%

14 ended early

Currently Active

5

trials recruiting

Total Trials

84

all time

Status Distribution
Active(6)
Completed(55)
Terminated(14)
Other(9)

Detailed Status

Completed55
Terminated10
unknown9
Withdrawn4
Recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
84
Active
5
Success Rate
84.6%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (8.4%)
Phase 215 (18.1%)
Phase 316 (19.3%)
Phase 428 (33.7%)
N/A17 (20.5%)

Trials by Status

withdrawn45%
active_not_recruiting11%
completed5565%
not_yet_recruiting11%
unknown911%
terminated1012%
recruiting45%

Recent Activity

Clinical Trials (84)

Showing 20 of 84 trialsScroll for more
NCT07208305Phase 3

Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

Recruiting
NCT07519447

Gastric Residual Volume and Aspiration Risk Following Intravenous Metoclopramide in Fasted Diabetic Patients Undergoing Elective Surgery

Completed
NCT03970720Phase 2

Restoration of Hypoglycemia Awareness With Metoclopramide

Recruiting
NCT06379217Phase 1

NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.

Active Not Recruiting
NCT04726592Phase 3

Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room

Terminated
NCT07100691Phase 4

Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery

Not Yet Recruiting
NCT02965963Not Applicable

The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During Exercise

Completed
NCT06898268Not Applicable

Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal Reflux

Completed
NCT05102591Phase 3

A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents

Completed
NCT03560583Not Applicable

Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients

Recruiting
NCT06297954Phase 3

Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding

Completed
NCT05731960Phase 4

Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean Delivery

Recruiting
NCT01851369Phase 1

TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas

Completed
NCT06390787Phase 2

The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics

Completed
NCT05496179Phase 1

The Effect of Prucalopride on Gastric Emptying in Intensive Care Unit Patients

Completed
NCT05533281Phase 4

Efficacy of Three Antiemetics in Preventing Nausea and Vomiting

Completed
NCT04252521Not Applicable

Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine

Completed
NCT05098067Phase 2

Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy

Completed
NCT04771481Phase 4

Metoclopramide for Acute Upper GI Bleeding

Completed
NCT05548985Not Applicable

Midodrine for Prophylaxis Against Post Spinal Hypotension in Elderly Population

Completed

Drug Details

Intervention Type
DRUG
Total Trials
84